A leading company oriented to virtual transformation.
A new survey through market research company Ipsos surveyed others around the world about their attitudes towards COVID-19 vaccines, and the effects reveal strong national differences in the hope that a vaccine will soon be available and willing to get vaccinated.
Many see a vaccine as the possibility of the world coming back to something closer to normal. The World Health Organization is tracking more than 170 candidate vaccines, nine of them in complex clinical trials. Vaccines take years to develop, but scientists hope to decline. this time for 12 to 18 months with the global coronavirus pandemic.
But if a vaccine arrives, it will only be effective if other people agree to get vaccinated, and the Ipsos study found that respondents differed widely from country to country on their attitudes toward vaccines.
See the 3 charts below to see how the global compares.
China stands out as the most pro-vaccine country studied, with 97% of respondents who said they would get a vaccine as soon as it became available. Russia at the other end of the spectrum, with almost a portion of all the Russians who said they had no purpose. to get vaccinated.
Last month, Russia approved one of its vaccine applicants for use in some patients before clinical trials were completed, which scientists in other countries have warned can erode confidence in international vaccines in the event of a problem.
Overall, 74% of other international people said they would get a COVID-19 vaccine.
The maximum moment is not an unusual reason: confidence that the vaccine will be effective. Lack of confidence in vaccine effectiveness can have disastrous consequences for combating the pandemic.
“The 26% deficit in vaccine confidence is significant enough to compromise the effectiveness of implementing a COVID-19 vaccine,” said Arnaud Bernaert of the World Economic Forum, according to a press release. The personal sector will come together to build Ok as True and ensure that production capacity meets the global source of a COVID-19 vaccination program. This will require cooperation between researchers and brands and public investment agreements that remove restrictions on access to vaccines. “
The big exception: China, where 87% of others said they think they would be offered a vaccine this year. Saudi Arabia (75%) India (74%) he’s also optimistic.
In the United States, about a third of the idea would be to have a vaccine until the end of the year.
Particularly pessimistic countries included Germany (24% believe it will be available until the end of 2020), Japan (22%) Poland (22%).
US fitness officials have not ruled out approval of a vaccine this year, although distribution disorders can limit the availability of the vaccine even after approval.